Cargando…

Ethical frameworks in clinical research processes during COVID-19: a scoping review

OBJECTIVES: In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasherman, Lawrence, Madariaga, Ainhoa, Liu, Qin, Bonilla, Luisa, McMullen, Michelle, Liu, Shiru (Lucy), Wang, Lisa, Fazelzad, Rouhi, Karakasis, Katherine, Heesters, Ann M, Oza, Amit M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313312/
https://www.ncbi.nlm.nih.gov/pubmed/34301656
http://dx.doi.org/10.1136/bmjopen-2020-047076
_version_ 1783729318908657664
author Kasherman, Lawrence
Madariaga, Ainhoa
Liu, Qin
Bonilla, Luisa
McMullen, Michelle
Liu, Shiru (Lucy)
Wang, Lisa
Fazelzad, Rouhi
Karakasis, Katherine
Heesters, Ann M
Oza, Amit M
author_facet Kasherman, Lawrence
Madariaga, Ainhoa
Liu, Qin
Bonilla, Luisa
McMullen, Michelle
Liu, Shiru (Lucy)
Wang, Lisa
Fazelzad, Rouhi
Karakasis, Katherine
Heesters, Ann M
Oza, Amit M
author_sort Kasherman, Lawrence
collection PubMed
description OBJECTIVES: In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this paper is to determine the rates of references surrounding the ethical oversight of research as reported in current COVID-19-related research publications. DESIGN: Scoping review. SETTING: Population-based observational or interventional studies from December 2019 to May 2020 with sample size of two or more. Studies were searched through electronic databases including Medline, EMBASE, and Cochrane CENTRAL Register of Controlled Trials. PARTICIPANTS: Eligibility criteria included participants within published studies who tested positive for COVID-19. MAIN OUTCOMES AND MEASURES: Data were extracted and charting methods included taking note of references to ethical frameworks, institutional review board (IRB), ethics committee (EC) or research ethics board (REB) involvement, consent processes, and other variables. RESULTS: 11 556 articles were screened, with 656 included in the final analysis. References to ethics were present in 530 (80.8%) studies, with 491 (74.8%) involving IRB/ECs/REBs and 126 (19.2%) not referencing ethics. Consent processes were outlined in 201 (30.6%) studies, with 198 (30.2%) reporting that they obtained consent waivers, however, 257 (39.2%) did not mention consent at all. Differences (p<0.001) in ethics-related references were apparent when analysed by continent, publication type, sample size and IF. CONCLUSIONS: The majority of published articles pertaining to COVID-19 research made mention of ethical considerations, however, national and regional variations in research ethics review requirements introduce heterogeneity between studies and raise important questions about the conduct of scientific research during global public emergencies. TRIAL REGISTRATION NUMBER: Open Science Framework: https://osfio/z67wb.
format Online
Article
Text
id pubmed-8313312
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-83133122021-07-27 Ethical frameworks in clinical research processes during COVID-19: a scoping review Kasherman, Lawrence Madariaga, Ainhoa Liu, Qin Bonilla, Luisa McMullen, Michelle Liu, Shiru (Lucy) Wang, Lisa Fazelzad, Rouhi Karakasis, Katherine Heesters, Ann M Oza, Amit M BMJ Open Ethics OBJECTIVES: In response to the COVID-19 pandemic there have been significant developments in research, its conduct and the supporting ethical framework. While many protocols have been delayed, halted or modified, other research efforts have been accelerated, generating controversy. The goal of this paper is to determine the rates of references surrounding the ethical oversight of research as reported in current COVID-19-related research publications. DESIGN: Scoping review. SETTING: Population-based observational or interventional studies from December 2019 to May 2020 with sample size of two or more. Studies were searched through electronic databases including Medline, EMBASE, and Cochrane CENTRAL Register of Controlled Trials. PARTICIPANTS: Eligibility criteria included participants within published studies who tested positive for COVID-19. MAIN OUTCOMES AND MEASURES: Data were extracted and charting methods included taking note of references to ethical frameworks, institutional review board (IRB), ethics committee (EC) or research ethics board (REB) involvement, consent processes, and other variables. RESULTS: 11 556 articles were screened, with 656 included in the final analysis. References to ethics were present in 530 (80.8%) studies, with 491 (74.8%) involving IRB/ECs/REBs and 126 (19.2%) not referencing ethics. Consent processes were outlined in 201 (30.6%) studies, with 198 (30.2%) reporting that they obtained consent waivers, however, 257 (39.2%) did not mention consent at all. Differences (p<0.001) in ethics-related references were apparent when analysed by continent, publication type, sample size and IF. CONCLUSIONS: The majority of published articles pertaining to COVID-19 research made mention of ethical considerations, however, national and regional variations in research ethics review requirements introduce heterogeneity between studies and raise important questions about the conduct of scientific research during global public emergencies. TRIAL REGISTRATION NUMBER: Open Science Framework: https://osfio/z67wb. BMJ Publishing Group 2021-07-23 /pmc/articles/PMC8313312/ /pubmed/34301656 http://dx.doi.org/10.1136/bmjopen-2020-047076 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Ethics
Kasherman, Lawrence
Madariaga, Ainhoa
Liu, Qin
Bonilla, Luisa
McMullen, Michelle
Liu, Shiru (Lucy)
Wang, Lisa
Fazelzad, Rouhi
Karakasis, Katherine
Heesters, Ann M
Oza, Amit M
Ethical frameworks in clinical research processes during COVID-19: a scoping review
title Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_full Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_fullStr Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_full_unstemmed Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_short Ethical frameworks in clinical research processes during COVID-19: a scoping review
title_sort ethical frameworks in clinical research processes during covid-19: a scoping review
topic Ethics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313312/
https://www.ncbi.nlm.nih.gov/pubmed/34301656
http://dx.doi.org/10.1136/bmjopen-2020-047076
work_keys_str_mv AT kashermanlawrence ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT madariagaainhoa ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT liuqin ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT bonillaluisa ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT mcmullenmichelle ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT liushirulucy ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT wanglisa ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT fazelzadrouhi ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT karakasiskatherine ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT heestersannm ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview
AT ozaamitm ethicalframeworksinclinicalresearchprocessesduringcovid19ascopingreview